Semler Scientific Inc. (NASDAQ:SMLR - Get Free Report)'s stock price fell 8.2% during trading on Tuesday . The company traded as low as $41.31 and last traded at $41.53. 178,722 shares were traded during mid-day trading, a decline of 69% from the average session volume of 570,919 shares. The stock had previously closed at $45.23.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on SMLR. Wall Street Zen lowered shares of Semler Scientific from a "buy" rating to a "sell" rating in a report on Thursday, May 22nd. Benchmark began coverage on shares of Semler Scientific in a report on Tuesday, July 8th. They set a "buy" rating and a $101.00 target price on the stock. Finally, Maxim Group raised shares of Semler Scientific to a "strong-buy" rating and set a $95.00 target price on the stock in a report on Wednesday, July 9th.
Read Our Latest Report on Semler Scientific
Semler Scientific Stock Performance
The firm has a market capitalization of $583.86 million, a P/E ratio of -16.36 and a beta of 1.39. The company has a current ratio of 0.52, a quick ratio of 0.51 and a debt-to-equity ratio of 0.59. The business's 50 day simple moving average is $37.47 and its two-hundred day simple moving average is $41.66.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its quarterly earnings results on Tuesday, May 13th. The company reported ($0.76) EPS for the quarter. The company had revenue of $8.84 million during the quarter. Semler Scientific had a positive return on equity of 19.75% and a negative net margin of 60.69%.
Hedge Funds Weigh In On Semler Scientific
Large investors have recently added to or reduced their stakes in the company. Interchange Capital Partners LLC purchased a new position in shares of Semler Scientific in the first quarter worth $46,502,000. Capital International Investors purchased a new position in shares of Semler Scientific in the fourth quarter worth $30,813,000. Susquehanna Advisors Group Inc. purchased a new position in shares of Semler Scientific in the fourth quarter worth $26,928,000. Driehaus Capital Management LLC purchased a new position in shares of Semler Scientific in the fourth quarter worth $10,122,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Semler Scientific by 226.1% in the first quarter. Charles Schwab Investment Management Inc. now owns 158,576 shares of the company's stock worth $5,740,000 after buying an additional 109,951 shares in the last quarter. Hedge funds and other institutional investors own 49.37% of the company's stock.
About Semler Scientific
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
